Trial Profile
Effect of GLANATEC ophthalmic solution 0.4% on corneal endothelium
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Ripasudil (Primary)
- Indications Diabetic retinopathy; Glaucoma; Ocular hypertension
- Focus Adverse reactions
- 05 Aug 2015 New trial record